Suppr超能文献

为接受早期临床试验入组的晚期癌症儿童提供服务的父母决策特点:系统评价。

Characteristics of parental decision-making for children with advanced cancer who are offered enrollment in early-phase clinical trials: A systematic review.

机构信息

Department of Pediatric Hematology and Oncology, Children's University Hospital, Vandoeuvre-lès-Nancy, France.

APEMAC, team MICS, Lorraine University, Nancy, France.

出版信息

Pediatr Hematol Oncol. 2020 Sep;37(6):500-529. doi: 10.1080/08880018.2020.1759738. Epub 2020 May 13.

Abstract

Limited research is available on parental decision-making regarding their children's participation in pediatric phase I oncology trials compared with the adult population. The objectives of this review were to describe: (1) the process of parental decision-making in this situation; (2) the optimal communication features physicians need when proposing inclusion in such trials; and (3) the place of the child/adolescent in the assent process. Thirty relevant studies meeting inclusion criteria were identified by searching five computerized databases (PubMed, Web of Science, Cairn, Psychinfo, EM Premium). Parental decision-making is a complex process based on hopeful expectations, multiple family considerations and the child's previous cancer experience. It is highly impacted by the quality of physicians' communication. A therapeutic alliance along with an empathetic attitude and a timely delivery of accurate information is essential. Due weight should be given to the voice of children or adolescents and their optimal level of involvement may be discussed depending on their age and maturity. They should be given age-adapted information in order to empower them to be rightfully and meaningfully involved in early-phase research. This review highlights the main gaps and necessary remedial actions to support an optimal patient care management in this situation. Physicians' training in communication, structured interdisciplinary teamwork and early integration of palliative care are three key challenges which need to be implemented to actively engage in optimization strategies which would improve patient care and family support when offering enrollment in a phase I trial.

摘要

关于父母在决定让孩子参与儿科肿瘤 I 期临床试验方面的决策,与成人相比,相关研究较少。本综述的目的在于描述:(1) 这种情况下父母决策的过程;(2) 医生在提出纳入此类试验时需要的最佳沟通特征;以及 (3) 孩子/青少年在同意过程中的地位。通过检索五个计算机数据库(PubMed、Web of Science、Cairn、Psychinfo、EM Premium),确定了 30 项符合纳入标准的相关研究。父母的决策是一个复杂的过程,基于充满希望的期望、多方面的家庭考虑以及孩子以前的癌症经历。它受到医生沟通质量的高度影响。建立治疗联盟,以及同理心和及时提供准确信息至关重要。应充分重视儿童或青少年的意见,根据他们的年龄和成熟度,可以讨论他们的最佳参与程度。应该向他们提供适合其年龄的信息,以使他们能够在早期研究中适当地、有意义地参与。本综述强调了主要差距和必要的补救措施,以支持在这种情况下进行最佳的患者护理管理。医生在沟通方面的培训、结构化的跨学科团队合作以及姑息治疗的早期整合是需要实施的三个关键挑战,以积极参与优化策略,从而在提供 I 期试验入组时改善患者护理和家庭支持。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验